Scientific Reports (Jan 2022)

Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer

  • Nan Yao,
  • Wenzai Shi,
  • Tong Liu,
  • Sarah Tan Siyin,
  • Weiqi Wang,
  • Ning Duan,
  • Guoshuai Xu,
  • Jun Qu

DOI
https://doi.org/10.1038/s41598-021-04342-0
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Male breast cancer (MBC) is rare. Due to limited information, MBC has always been understudied. We conducted a retrospective population-based cohort study using data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program. The clinical and biological features of female breast cancer (FBC) patients were compared with MBC patients. Cox regression models and competing risks analyses were used to identify risk factors associated with cancer-related survival in MBC and FBC groups. Results showed that MBC patients suffered from higher TNM stages, tumor grades, and a higher percentage of hormone receptor-positive tumors, compared with FBC patients (all p 0.05). Tumor location was an independent prognostic factor for both gender groups.